December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Corneal Gene Therapy with IL-1 RA Inhibits Corneal Neovascularisation & Suppresses Rejection in Penetrating Keratoplasty
Author Affiliations & Notes
  • NA Afshari
    Ophthalmology Duke University Eye Center Durham NC
  • CB T McMullen
    School of Biomedical Sciences University of Ulster Coleraine United Kingdom
  • JE Moore
    Ophthalmology Queen's University of Belfast United Kingdom
  • IL Campbell
    Scripps Research Institute CA
  • T Usui
    Harvard Medical School MA
  • Z Haskova
    Harvard Medical School MA
  • B Kasander
    Harvard Medical School MA
  • AP Adamis
    Harvard Medical School MA
  • Footnotes
    Commercial Relationships   N.A. Afshari, None; C.B.T. McMullen, None; J.E. Moore, None; I.L. Campbell, None; T. Usui, None; Z. Haskova, None; B. Kasander, None; A.P. Adamis, None. Grant Identification: NIH EY 11627 EY 12611 Fight for Sight R&D
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2271. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      NA Afshari, CB T McMullen, JE Moore, IL Campbell, T Usui, Z Haskova, B Kasander, AP Adamis; Corneal Gene Therapy with IL-1 RA Inhibits Corneal Neovascularisation & Suppresses Rejection in Penetrating Keratoplasty . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2271.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: The purpose of this study was to modulate the inflammatory environment associated with penetrating keratoplasty via gene therapy with the anti-inflammatory cytokine IL-1 RA in an attempt to alter graft survival and reduce vascularization. Methods: In a mouse model, donor corneas were transfected with IL-1 RA by injection of naked plasmid vector pIRES-EGFP-IL-1 RA 24 hours prior to penetrating keratoplasty. Corneas transfected with pIRES-EGFP (green fluorescent protein) plasmid served as controls. Statement of corneal IL-1 RA following transfection with pIRES-EGFP-IL-1 RA was assessed at 24 hours post transfection using real time PCR and Western blotting. Graft survival and graft vascularization was monitored for 56 days post engraftment. In addition, corneal VEGF protein statement was measured using ELISA at 2.5 days post engraftment with and without IL-1 RA transfection. Results: Naked gene transfer of IL-1 RA to corneal buttons 24 hours prior to their use in penetrating keratoplasty resulted in a statistically significant increase in graft survival (Kaplan Meier Survival curve, p<0.05 n=15 mice) and a decrease in graft vascularization. 2.5 days post penetrating keratoplasty corneal VEGF protein expression increased (control vs. penetrating keratoplasty, 9.9 pg/ml vs. 110 pg/ml n=4 mice p<0.05). In corneas where the button was transfected with IL-1 RA prior to transplantation a statistically significant reduction was noted in the amount of VEGF protein expressed in corneas 2.5 days post penetrating keratoplasty (IL-1 RA transfected vs. control GFP transfected, 78 pg/ml vs. 110 pg/ml, n=5 mice p=0.012). Conclusion: Transfection of a corneal donor button with IL-1 RA prior to penetrating keratoplasty produced a significant alteration in the cytokine profile which suppressed corneal neovascularization and also enhanced graft survival. VEGF levels were increased post keratoplasty but corneal transfection with IL-1RA suppressed this increase. These findings demonstrate the feasibility of using transient cytokine gene statement, either in donor or recipient corneal tissue, to beneficially alter the interaction between grafted tissue and host.

Keywords: 370 cornea: basic science • 607 transplantation • 380 cytokines/chemokines 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.